Boram acquires Newgex

Published: 2009-04-06 06:56:00

Updated: 2009-04-06 06:56:00

Boram Pharm announced on March 31 that it has acquired Newgex, Inc., a local biopharmaceutical company and that this acquisition will add growth momentum to Boram’s research and development projects.

The merged company will have two joint CEOs – Dr. Lee Tae-kyu and Mr. Kim Joon-young. It will...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK